WILMINGTON, MASSACHUSETTS--(MARKET WIRE)--Aug 15, 2007 -- DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, will present at the Noble Financial Two Double-0-Seven Small Cap Conference/Micro Cap Symposium Conference being held August 20 and 21, 2007 at the Charleston Place Hotel in Charleston, South Carolina.
